The JNC 8 guidelines are based on 27 large clinical trials that are often discussed in isolation, but have never been aggregated into a single source until now.
The FDA has awarded Breakthrough Therapy status to crizotinib (Xalkori) for ROS1-positive non-small cell lung cancer.
Between the busy, fast-paced working conditions and the sheer amount of prescriptions being processed, the heightened possibility for error is certainly a viable concern for pharmacists and pharmacy technicians.
HIV-infected men may be more sensitive to alcohol’s effects.
Four fast-acting liquid Mucinex medicines have been voluntarily recalled by RB due to mislabeling.